Mozobil

(plerixafor)
1.2 ML plerixafor 20 MG/ML Injection [Mozobil]
NO BOXED WARNING

Dosage & administration

biomarker testing

Mozobil clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Mozobil prescribing information

prior authorization

Mozobil prior authorization resources

Most recent Mozobil prior authorization forms

View By Payer
Verified: Nov 27, 2023Cigna - Mozobil Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Appeal
Learn More

Benefits investigation

Sanofi Patient Connection Application - English
Sanofi Patient Connection Application - Spanish
Learn More

Reimbursement help (FRM)

Reimbusement Information
Learn More

financial assistance

Mozobil financial assistance options

Foundation programs

under insured
no insurance
goverment insurance
65+
Sanofi Patient Connection Application - English
Sanofi Patient Connection Application - Spanish
Learn More

patient education

Mozobil patient education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Mozobil
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Mozobil FAQs

How is the dosage of Mozobil?Mozobil is available in 1 dosages, including 20 mg/ml Injection 1.2 ml
What does Mozobil treat?Mozobil treats Non-Hodgkin Lymphoma and Multiple Myeloma
What is Mozobil made of?Mozobil contains plerixafor which is a Hematopoietic Stem Cell Mobilizer
How Is Mozobil Administered?Mozobil is administered as a Injectable
FAQ Data Source